SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-123599
Filing Date
2016-09-12
Accepted
2016-09-12 16:09:28
Documents
2
Period of Report
2016-09-09
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v448692_8k.htm 8-K 16686
2 EXHIBIT 10.01 v448692_ex10-01.htm EX-10.01 51638
  Complete submission text file 0001144204-16-123599.txt   69557
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 161881100
SIC: 2834 Pharmaceutical Preparations